1. Factors associated with transfusion requirements during treatment for acute myelogenous leukemia

   • G. Favre
   • M. Fopp
   • A. Gratwohl

   Original Article Pages: 153 - 160

2. Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia

   • O. G. Ottmann
   • A. Ganser
   • D. Hoelzer

   Original Article Pages: 161 - 167

3. Effect of recombinant human erythropoietin after allogeneic bone marrow transplantation

   • H. Link
   • T. Brune
   • H. Heinrichs

   Original Article Pages: 169 - 173

4. The tolerability of continuous intravenous infusion of interleukin-3 after DHAP chemotherapy in patients with relapsed malignant lymphoma

   • J. M. M. Raemaekers
   • G. W. van Imhoff
   • W. E. Fibbe

   Original Article Pages: 175 - 181

5. Serum erythropoietin levels in thalassemia intermedia

   • F. Dore
   • S. Bonfigli
   • M. Longinotti

   Original Article Pages: 183 - 186

6. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: A report from the international agranulocytosis and aplastic anemia study

   • M. Levy
   • J. P. Kelly
   • S. Shapiro

   Original Article Pages: 187 - 190

7. The acute infection-associated hemolytic anemia of childhood: Immunofluorescent detection of microbial antigens altering the erythrocyte membrane

   • R. -C. Seitz
   • G. Buschermöhle
   • H. H. Hellwege

   Original Article Pages: 191 - 196

8. GPI Mount Scopus — a variant of glucosephosphate isomerase deficiency

   • O. Shalev
   • R. S. Shalev
   • E. Beutler

   Case Report Pages: 197 - 200

9. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor

   • M. Katoh
   • K. Shikoshi
   • T. Shirai

   Letter to the Editors Pages: 201 - 202

10. Announcement

    Announcement Pages: 203 - 203